We show pictures, they show curves

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 12, 2010, Pages 1170-1175

  Ridge, John A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; COOPERATION; HEAD AND NECK CANCER; HUMAN; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURGICAL TECHNOLOGY; TREATMENT OUTCOME;

HEAD AND NECK NEOPLASMS; HUMANS; PRACTICE GUIDELINES AS TOPIC; SURGICAL PROCEDURES, OPERATIVE;

EID: 78650835504     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.221     Document Type: Conference Paper

References (14)

1. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: v.1.2010 Head and Neck Cancers. Fort Washington, PA: National Comprehensive Cancer Network; 2010.
2. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685-1690.
3. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4):1310-1317. (Pubitemid 28175745)
4. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338(25):1798-1804.
5. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567-578.
6. Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 2009;31(6):748-758.
7. Vermorken JB, Remenar E, van Herpen C, et al; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695-1704.
8. Langer CJ, Lee J-W, Quon H, et al. Phase II Study of C225 (Erbitux or cetuximab) in combination with cisplatin and definitive radiation in unresectable stage IV squamous cell carcinoma of the head and neck [LA-SCCHN]: a trial of the Eastern Cooperative Oncology Group (E3303) [abstract 6006]. J Clin Oncol. 2008; 26(15)(suppl):317s.
9. Trotti A, Pajak TF, Gwede CK, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 2007;8(7):613-624. (Pubitemid 46995620)
10. Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010;28(8):1395-1400.
11. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630-5636.
12. Fischer CA, Zlobec I, Green E, et al. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer. 2010;126(5):1256-1262.
13. Holsinger FC, Kies MS, Diaz EM Jr, et al. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol. 2009;27(12):1976-1982.
14. Licitra L, Grandi C, Guzzo M, et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol. 2003;21(2):327-333. (Pubitemid 46606163)